Gastro Esophageal Reflux: Clinical Trials

4 trials for Gastro Esophageal Reflux, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 recruiting, 1 terminated, 1 unknown. 4 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 44Completed 1, Recruiting 1, Terminated 1, Unknown 1

Follow Gastro Esophageal Reflux: new trials by email Literature Review of Gastro Esophageal Reflux trials Research Report on Gastro Esophageal Reflux

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Gastrointestinal Dysmotility on Aspiration Risk
Prucalopride, Famotidine - Esophageal Motility Disorders, Gastric Motor Dysfunction
Phase 4RecruitingBoston Children's Hospital1202025-02-132026-08-03
Efficacy and Safety of EsoDuo®
EsoDuo® Tablet - Gastro Esophageal Reflux
Phase 4UnknownChong Kun Dang Pharmaceutical1802022-11-252024-05-28
Effectiveness of Vonoprazan vs Omeprazole as Empiric Therapy for Gastroesophageal Reflux Disease (GERD) Patients Without Alarm Features
Vonoprazan, Omeprazole - GERD, Gastro Esophageal Reflux
Phase 4TerminatedSt. Luke's Medical Center, Philippines822019-05-262023-11-22
Effect of Citalopram on Reflux Episodes in Healthy Volunteers
Citalopram HCl, Placebos - Gastro Esophageal Reflux
Phase 4CompletedUniversitaire Ziekenhuizen KU Leuven192017-02-012018-11-20

Narrower conditions

Gastroesophageal Reflux (4)  ·  Esophageal Motility Disorders (1)  ·  Pneumonia, Aspiration (1)

Broader conditions

Deglutition Disorders (4)  ·  Digestive System Diseases (4)  ·  Esophageal Diseases (4)  ·  Gastrointestinal Diseases (4)  ·  Esophageal Motility Disorders (3)  ·  Infections (1)  ·  Lung Diseases (1)  ·  Pneumonia (1)  ·  Respiratory Tract Diseases (1)  ·  Respiratory Tract Infections (1)

Interventions

1-(5-(2-fluorophenyl)-1-(pyridin-3-ylsulfonyl)-1H-pyrrol-3-yl)-N-methylmethanamine (1)  ·  Famotidine (1)  ·  Omeprazole (1)  ·  prucalopride (1)

Sponsors

Boston Children's Hospital (1)  ·  Chong Kun Dang Pharmaceutical (1)  ·  St. Luke's Medical Center, Philippines (1)  ·  Universitaire Ziekenhuizen KU Leuven (1)

Countries

Belgium (1)  ·  Philippines (1)  ·  South Korea (1)  ·  United States (1)

Top investigators

Hwoon-Yong Jung, M.D, PhD (1)  ·  Jan Tack, Prof. (1)  ·  Nicodemus L Ong, MD (1)

Results publications

PMID 26559637, PMID 28119763, PMID 28567114, PMID 28894571, PMID 29739175, PMID 30504527